Search

everythinglearnresearchcommunity

for

Search:↓

The document explains how certain drugs block hormones to treat cancers like breast and prostate cancer.

Antiandrogen therapy may help treat hidradenitis suppurativa.

Androgenic steroids can slow down or stop the growth of certain skin fungi.

Anti-androgens can help reduce the effects of male hormones on the skin.

New treatments for male hypogonadism are easier to use and target specific tissues to reduce side effects.

Camellia oleifera seed shell polyphenols and 1,3,6-tri-O-galloylglucose can help treat hair loss by reducing certain hormones and promoting hair growth.

Flutamide improves female hair loss when other treatments fail, but may cause liver toxicity.

Androgens and SARMs play a role in body mass, frailty, skin health, and hair growth, and are used in treating prostate cancer, acne, and hair loss, with potential for new uses and improved versions in the future.

Dutasteride and finasteride affect different cell types differently.

People with hair loss have more androgen receptors and enzymes in certain follicles, with men and women showing different patterns.

Prostate cancer cells can make their own androgens to activate the androgen receptor, and treatments like abiraterone may increase this ability, suggesting new therapies should target the entire steroid-making pathway.

Targeting androgen receptors could be a promising way to treat skin disorders with fewer side effects.

Lowering testosterone speeds up wound healing in male mice.

Reduced AR gene methylation may cause early pubic hair growth in girls.

Testing for CAG repeat polymorphism in the androgen receptor gene is not currently recommended for managing hypogonadism.

Scutellaria baicalensis extract and baicalin may help prevent hair loss.

Short-term finasteride treatment may lower some cell death factors in prostate cancer cells.

The androgen receptor is a promising target for breast cancer treatment, especially in triple-negative cases, but more research is needed for personalized therapies.

Certain changes to the B-ring of androgen receptor ligands can increase their effectiveness for potential treatments of muscle and bone conditions.

A compound made by Pfizer can potentially stimulate hair growth and reduce oil production, making it a good candidate for topical use.

Longer CAG and GGN repeats increase alopecia risk, but no significant link to post-finasteride syndrome found.

Adding cerium(III) chloride to Grignard reagents improves the making of compounds that could treat prostate issues and hair loss.

Allopregnanolone is needed for certain brain processing issues caused by D1 dopamine receptor activation.

Changes in testosterone and estrogen receptor genes can affect how men age, influencing body fat, hair patterns, and possibly leading to skin disorders.

A new compound was created in 2010 that can control oil production when applied to the skin, and its effects are completely reversible after two weeks.

We need better ways to test and understand SARMs to make safer and more effective treatments.

Chemicals called 4-(alkylthio)- and 4-(arylthio)-benzonitrile derivatives can potentially reduce oil production on skin, which could help treat conditions like acne and hair loss.

Scientists made a chemical (compound 4e) that can be applied on skin to reduce oil production, which can help with acne, but it might cause skin sensitivity to light.

Longer CAG repeats in gene linked to more severe hair loss in females.

Clascoterone is a new, effective, and safe acne treatment without systemic side effects.